Follow
Christoph Alexiou
Christoph Alexiou
Else Kröner-Fresenius Stiftungsprofessor für Nanomedizin, Leiter der Sektion für Experimentelle Onkologie und Nanomedizin (SEON), Universitätsklinikum Erlangen
Verified email at uk-erlangen.de - Homepage
Title
Cited by
Cited by
Year
Locoregional cancer treatment with magnetic drug targeting
C Alexiou, W Arnold, RJ Klein, FG Parak, P Hulin, C Bergemann, ...
Cancer research 60 (23), 6641-6648, 2000
13522000
Clinical applications of magnetic drug targeting
AS Lübbe, C Alexiou, C Bergemann
Journal of Surgical Research 95 (2), 200-206, 2001
12462001
Diverse applications of nanomedicine
B Pelaz, C Alexiou, RA Alvarez-Puebla, F Alves, AM Andrews, S Ashraf, ...
ACS nano 11 (3), 2313-2381, 2017
12402017
Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts
C Alexiou, RJ Kau, H Dietzfelbinger, M Kremer, JC Spieß, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1999
8441999
Targeting cancer cells: magnetic nanoparticles as drug carriers
C Alexiou, RJ Schmid, R Jurgons, M Kremer, G Wanner, C Bergemann, ...
European biophysics journal 35, 446-450, 2006
5262006
Magnetic nanoparticle-based drug delivery for cancer therapy
R Tietze, J Zaloga, H Unterweger, S Lyer, RP Friedrich, C Janko, M Pöttler, ...
Biochemical and biophysical research communications 468 (3), 463-470, 2015
4652015
Drug loaded magnetic nanoparticles for cancer therapy
R Jurgons, C Seliger, A Hilpert, L Trahms, S Odenbach, C Alexiou
Journal of Physics: Condensed Matter 18 (38), S2893, 2006
4022006
Magnetic drug targeting—biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment
C Alexiou, R Jurgons, RJ Schmid, C Bergemann, J Henke, W Erhard, ...
Journal of drug targeting 11 (3), 139-149, 2003
3892003
In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles
C Alexiou, R Jurgons, R Schmid, A Hilpert, C Bergemann, F Parak, H Iro
Journal of Magnetism and Magnetic Materials 293 (1), 389-393, 2005
2612005
Efficient drug-delivery using magnetic nanoparticles—biodistribution and therapeutic effects in tumour bearing rabbits
R Tietze, S Lyer, S Dürr, T Struffert, T Engelhorn, M Schwarz, E Eckert, ...
Nanomedicine: Nanotechnology, Biology and Medicine 9 (7), 961-971, 2013
2602013
Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting
C Alexiou, W Arnold, P Hulin, RJ Klein, H Renz, FG Parak, C Bergemann, ...
Journal of Magnetism and Magnetic Materials 225 (1-2), 187-193, 2001
2182001
Sudden sensorineural hearing loss: does application of glucocorticoids make sense?
C Alexiou, W Arnold, C Fauser, B Schratzenstaller, B Gloddek, ...
Archives of otolaryngology–head & neck surgery 127 (3), 253-258, 2001
1862001
A high field gradient magnet for magnetic drug targeting
C Alexiou, D Diehl, P Henninger, H Iro, R Rockelein, W Schmidt, H Weber
IEEE Transactions on applied superconductivity 16 (2), 1527-1530, 2006
1812006
Medical applications of magnetic nanoparticles
C Alexiou, R Jurgons, C Seliger, H Iro
Journal of nanoscience and nanotechnology 6 (9-10), 2762-2768, 2006
1772006
Cancer therapy with drug loaded magnetic nanoparticles—magnetic drug targeting
C Alexiou, R Tietze, E Schreiber, R Jurgons, H Richter, L Trahms, H Rahn, ...
Journal of Magnetism and Magnetic Materials 323 (10), 1404-1407, 2011
1692011
Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis
M Kremer, G Ott, M Nathrath, K Specht, K Stecker, C Alexiou, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005
1642005
Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting
RJ Kau, C Alexiou, C Laubenbacher, M Werner, M Schwaiger, W Arnold
Archives of Otolaryngology–Head & Neck Surgery 125 (12), 1322-1328, 1999
1541999
Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting
C Alexiou, R Jurgons, C Seliger, O Brunke, H Iro, S Odenbach
Anticancer research 27 (4A), 2019-2022, 2007
1462007
Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment
GF Heidkamp, J Sander, CHK Lehmann, L Heger, N Eissing, A Baranska, ...
Science immunology 1 (6), eaai7677, 2016
1432016
Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: Evaluation of size-dependent imaging properties, storage stability and safety
H Unterweger, L Dézsi, J Matuszak, C Janko, M Poettler, J Jordan, ...
International journal of nanomedicine, 1899-1915, 2018
1402018
The system can't perform the operation now. Try again later.
Articles 1–20